Regulus Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Jan 24 | SellUS$6,510 | Crispina Calsada | Individual | 5,468 | US$1.19 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,212 | 0.00491% |
Individual Insiders | 1,102,197 | 1.68% |
Hedge Funds | 3,679,854 | 5.62% |
General Public | 11,487,977 | 17.5% |
VC/PE Firms | 17,717,802 | 27.1% |
Institutions | 31,474,834 | 48.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 236.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
12,852,654 | US$26.2m | 232% | 0.07% | |||
6,467,802 | US$13.2m | 232% | 0.86% | |||
6,250,000 | US$12.8m | 0% | 0.18% | |||
5,000,000 | US$10.2m | 0% | 0.88% | |||
3,679,854 | US$7.5m | 0% | 0.01% | |||
3,266,566 | US$6.7m | 0% | 0.19% | |||
2,922,600 | US$6.0m | 0% | no data | |||
1,875,226 | US$3.8m | 0% | no data | |||
1,562,500 | US$3.2m | 0% | 0.3% | |||
1,406,250 | US$2.9m | 0% | 1.23% | |||
1,155,516 | US$2.4m | 0% | no data | |||
1,070,548 | US$2.2m | -3.65% | 0.57% | |||
978,388 | US$2.0m | 34.3% | no data | |||
937,500 | US$1.9m | 0% | 0.01% | |||
740,215 | US$1.5m | 158% | no data | |||
625,000 | US$1.3m | 0% | 0.16% | |||
625,000 | US$1.3m | 0% | 0.01% | |||
536,400 | US$1.1m | 0% | 0.04% | |||
402,504 | US$821.1k | 126% | 0.77% | |||
227,419 | US$463.9k | 0% | no data | |||
185,183 | US$377.8k | 0% | 0.07% | |||
170,308 | US$347.4k | 0% | 0.08% | |||
160,590 | US$327.6k | 31.1% | no data | |||
132,470 | US$270.2k | 229% | 0.02% | |||
113,480 | US$231.5k | 0% | no data |